The inhibitor of prothrombin conversion in plasma of patients on oral anticoagulant treatment

Thromb Haemost. 1981 Jun 30;45(3):237-41.

Abstract

Pooled plasma of patients under stable oral anticoagulation has been analysed with respect to the presence of the vitamin-K dependent factors (factors II, VII, IX and X). Of all factors 1.5-2 times more antigen than procoagulant activity was present. The concentration of factors II, X (measured spectrophotometrically) and VI is about 0.25 U/ml while factor IX is slightly higher. Coagulation assays of factor X always gave lower values than the spectrophotometric assay. This discrepancy was not influenced by the removal of either factor II-, factor VII- or factor IX antigen. However, when the factor X antigen was replaced by normal factor X, all factor X assay gave identical results, indicating that PIVKA X is responsible for these discrepancies. Using the technic of the Thrombotest-dilution curve it was shown that PIVKA X is the factor that causes the abnormal prolongation of ox-brain prothrombin time in these plasmas.

MeSH terms

  • Administration, Oral
  • Adult
  • Anticoagulants / pharmacology*
  • Biomarkers*
  • Electrophoresis, Agar Gel
  • Factor IX / analysis
  • Factor IX / immunology
  • Factor VII / analysis
  • Factor VII / immunology
  • Factor X / analysis
  • Factor X / immunology
  • Humans
  • Partial Thromboplastin Time
  • Protein Precursors / analysis*
  • Prothrombin / analysis*
  • Prothrombin / immunology
  • Prothrombin Time*
  • Spectrophotometry
  • Vitamin K / analysis
  • Vitamin K / immunology

Substances

  • Anticoagulants
  • Biomarkers
  • Protein Precursors
  • Vitamin K
  • acarboxyprothrombin
  • Factor VII
  • Prothrombin
  • Factor IX
  • Factor X